Author name: li6230933@gmail.com

Orforglipron, an oral GLP-1 agonist, overcomes injection limitations with 29-49h half-life and enzyme resistance. Phase II/III trials show 14.7% weight loss and 1.48% HbA1c reduction. Tianming Pharma provides certified intermediates.

Ergothioneine (EGT) delivers comprehensive skin benefits via antioxidant, anti-inflammatory, photoprotective, and collagen-stimulating actions.

Ergothioneine, hailed as the “Longevity Vitamin,” targets mitochondria via OCTN1 transporters, offering unparalleled antioxidant, anti-fatigue, and anti-aging effects. Tianming Pharma details L-form purity (>99.99%), glutathione synergy, and science-backed alternatives like NMN/PQQ.

Orforglipron’s non-peptide scaffold (23 atoms) enables oral GLP-1 therapy via acid-stable triazole core, (R)-chlorophenyl chiral targeting, and pyridine N-oxide H-bonding. Tianming Pharma provides key intermediates for scalable synthesis.

We have made a major breakthrough in the production of orforglipron intermediates. We now offer a range of orforglipron intermediates with detailed information. Please contact us for more information to meet your pharmaceutical needs.

This article examines six pivotal trends reshaping the 2025 pharma intermediates sector: Asia’s manufacturing evolution, continuous production adoption, AI-driven R&D acceleration, ESG compliance pressures, nearshoring strategies, and biomanufacturing breakthroughs.

This article explores Idebenone, a supercharged antioxidant surpassing Vitamins C/E. It details its molecular advantages, anti-aging efficacy, and practical usage tips. Learn to select high-purity Idebenone products.

As a leading API/intermediate manufacturer, we showcase advanced synthesis tech and regulatory-ready solutions at CPHI 2025. Booth No.: W2G30

Expert analysis of API synthesis complexities: route selection trade-offs, scale-up challenges, impurity control tactics, and green chemistry innovations. Includes industrial case studies on yield optimization and troubleshooting.